GRIN2A and schizophrenia: These dysfunctions are clinically associated with cognitive impairment in schizophrenia patients, with postmortem studies demonstrating low expression of GRIN2A in the dorsolateral prefrontal cortex and AMPA receptor trafficking in both schizophrenic patients and controls [133].